October 19, 2017 9:12 AM ET


Company Overview of CROMA-PHARMA GmbH

Company Overview

CROMA-PHARMA GmbH, a pharmaceutical company, develops, manufactures, and distributes products in aesthetic dermatology field. The company offers injectable gels based on hyaluronic acid of non-animal origin for non-surgical beauty treatments and aesthetic indications, such as the correction of facial wrinkles and folds, lines, cutaneous depressions, facial contours, and the creation of volume. It also offers skincare products, which include hyaluron based day and night creams, serums, body lotions, face masks, moisturizing gels, anti-ageing serums, and essence recovery products; and lift products, such as a line of sutures for lifting and revitalizing effect, and a line of lifting threads ma...

Industriezeile 6

Leobendorf,  2100


Founded in 1976


43 22 62 684 68 0


43 22 62 684 68 165

Key Executives for CROMA-PHARMA GmbH

Chief Executive Officer, Managing Director and Member of Management Board
Managing Director and Member of Management Board
Managing Director and Member of Management Board
Compensation as of Fiscal Year 2017.

CROMA-PHARMA GmbH Key Developments

Sun Moral International (HK) Ltd. Enters Joint Venture Agreements with CROMA-Pharma GmbH

The board of directors of Sihuan Pharmaceutical Holdings Group Ltd. (the company or Sihuan Pharmaceutical together with its subsidiaries, the group) announced that Sun Moral International (HK) Ltd., a wholly-owned subsidiary of the company, recently entered into a series of agreements with CROMA-Pharma GmbH to establish joint venture company SunCro Aesthetic & Cosmetic International Co. Limited (SunCro), which is owned as to 74.9% by the group and 25.1% by Croma-Pharma. SunCro constitutes a subsidiary of the group. SunCro is principally engaged in the marketing of minimally-invasive aesthetic products. Under the joint venture arrangements, the Group will provide its multi-channel distribution and marketing knowledge in Mainland China while Croma-Pharma will contribute its experience and intellectual properties and licences of products.

Croma-Pharma Gmbh Signs Comprehensive Licensing and Distribution Agreement with Universkin SAS

Croma-Pharma GmbH signed a comprehensive licensing and distribution agreement with UNIVERSKIN SAS of France. The cooperation was concluded for at least 8 years. The exclusive licensing and distribution rights for all UNIVERSKIN products refer to European countries, namely Germany, Austria, France, Poland, Spain, Portugal, the Netherlands and overseas territories such as Australia, Canada and Brazil. For the licenses and distribution rights Croma-Pharma paid an undisclosed amount in a multimillion Euro range. The agreement shall enter into force on January 1st 2017. Under its premium brand Princess ®, which is exclusively available through dermatologists and pharmacies, Croma-Pharma offers a comprehensive range of products in the field of non-invasive and minimally-invasive aesthetic medicine. The portfolio includes products based on Hyaluronic Acid like intradermal fillers, lifting threads, face masks, serums and the True Hyaluron series. Currently, extensive studies are being conducted in Europe and the USA for the approval of Croma's new Botulinum Neurotoxin product, which is expected to be approved in 2019.

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CROMA-PHARMA GmbH, please visit www.croma.at. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.